On the armament and appearances of human myeloid-derived suppressor cells von Poschke, Isabel, Kiessling, Rolf

Volltext

A vaccine targeting mutant IDH1 in newly diagnosed glioma von Platten, Michael, Bunse, Lukas, Wick, Antje, Bunse, Theresa, Le Cornet, Lucian, Harting, Inga, Sahm, Felix, Sanghvi, Khwab, Tan, Chin Leng, Poschke, Isabel, Green, Edward, Justesen, Sune, Behrens, Geoffrey A., Breckwoldt, Michael O., Freitag, Angelika, Rother, Lisa-Marie, Schmitt, Anita, Schnell, Oliver, Hense, Jörg, Misch, Martin, Krex, Dietmar, Stevanovic, Stefan, Tabatabai, Ghazaleh, Steinbach, Joachim P., Bendszus, Martin, von Deimling, Andreas, Schmitt, Michael, Wick, Wolfgang

Volltext

Humoral and cellular responses after COVID-19 vaccination in anti-CD20-treated lymphoma patients von Liebers, Nora, Speer, Claudius, Benning, Louise, Bruch, Peter-Martin, Kraemer, Isabelle, Meissner, Julia, Schnitzler, Paul, Kräusslich, Hans-Georg, Dreger, Peter, Mueller-Tidow, Carsten, Poschke, Isabel, Dietrich, Sascha

Volltext

Immature Immunosuppressive CD14+HLA-DR-/low Cells in Melanoma Patients Are Stat3hi and Overexpress CD80, CD83, and DC-Sign von POSCHKE, Isabel, MOUGIAKAKOS, Dimitrios, HANSSON, Johan, MASUCCI, Giuseppe V, KIESSLING, Rolf

Volltext

The Outcome of Ex Vivo TIL Expansion Is Highly Influenced by Spatial Heterogeneity of the Tumor T-Cell Repertoire and Differences in Intrinsic In Vitro Growth Capacity between T-Ce... von Poschke, Isabel C., Hassel, Jessica C., Rodriguez-Ehrenfried, Aaron, Lindner, Katharina A. M., Heras-Murillo, Ignacio, Appel, Lena M., Lehmann, Johanna, Lovgren, Tanja, Wickstrom, Stina L., Lauenstein, Claudia, Roth, Jasmin, Koenig, Anna-Katharina, Haanen, John B. A. G., van den Berg, Joost, Kiessling, Rolf, Bergmann, Frank, Flossdorf, Michael, Strobel, Oliver, Offringa, Rienk

Volltext

Melanoma-Educated CD14+ Cells Acquire a Myeloid-Derived Suppressor Cell Phenotype through COX-2-Dependent Mechanisms von MAO, Yumeng, POSCHKE, Isabel, WENNERBERG, Erik, DE COANA, Yago Pico, BRAGE, Suzanne Egyhazi, SCHULTZ, Inkeri, HANSSON, Johan, MASUCCI, Giuseppe, LUNDQVIST, Andreas, KIESSLING, Rolf

Volltext

Primary Human Tumor Cells Expressing CD155 Impair Tumor Targeting by Down-Regulating DNAM-1 on NK Cells von Carlsten, Mattias, Norell, Hakan, Bryceson, Yenan T, Poschke, Isabel, Schedvins, Kjell, Ljunggren, Hans-Gustaf, Kiessling, Rolf, Malmberg, Karl-Johan

Volltext

Engineering antigen-specific primary human NK cells against HER-2 positive carcinomas von Kruschinski, Anna, Moosmann, Andreas, Poschke, Isabel, Norell, Håkan, Chmielewski, Markus, Seliger, Barbara, Kiessling, Rolf, Blankenstein, Thomas, Abken, Hinrich, Charo, Jehad

Volltext

AMPLIFY-NEOVAC: a randomized, 3-arm multicenter phase I trial to assess safety, tolerability and immunogenicity of IDH1-vac combined with an immune checkpoint inhibitor targeting p... von Bunse, Lukas, Rupp, Anne-Kathleen, Poschke, Isabel, Bunse, Theresa, Lindner, Katharina, Wick, Antje, Blobner, Jens, Misch, Martin, Tabatabai, Ghazaleh, Glas, Martin, Schnell, Oliver, Gempt, Jens, Denk, Monika, Reifenberger, Guido, Bendszus, Martin, Wuchter, Patrick, Steinbach, Joachim P, Wick, Wolfgang, Platten, Michael

Volltext

Complete and long-lasting clinical responses in immune checkpoint inhibitor-resistant, metastasized melanoma treated with adoptive T cell transfer combined with DC vaccination von Lövgren, Tanja, Wolodarski, Maria, Wickström, Stina, Edbäck, Ulrika, Wallin, Mette, Martell, Eva, Markland, Katrin, Blomberg, Pontus, Nyström, Maria, Lundqvist, Andreas, Jacobsson, Hans, Ullenhag, Gustav, Ljungman, Per, Hansson, Johan, Masucci, Giuseppe, Tell, Roger, Poschke, Isabel, Adamson, Lars, Mattsson, Jonas, Kiessling, Rolf

Volltext

INFORM2 NivEnt: The first trial of the INFORM2 biomarker driven phase I/II trial series: the combination of nivolumab and entinostat in children and adolescents with refractory hig... von van Tilburg, Cornelis M., Witt, Ruth, Heiss, Melanie, Pajtler, Kristian W., Plass, Christoph, Poschke, Isabel, Platten, Michael, Harting, Inga, Sedlaczek, Oliver, Freitag, Angelika, Meyrath, David, Taylor, Lenka, Balasubramanian, Gnana Prakash, Jaeger, Natalie, Pfaff, Elke, Jones, Barbara C., Milde, Till, Pfister, Stefan M., Jones, David T. W., Kopp-Schneider, Annette, Witt, Olaf

Volltext

Cancer Neoepitopes for Immunotherapy: Discordance Between Tumor-Infiltrating T Cell Reactivity and Tumor MHC Peptidome Display von Wickström, Stina L, Lövgren, Tanja, Volkmar, Michael, Reinhold, Bruce, Duke-Cohan, Jonathan S, Hartmann, Laura, Rebmann, Janina, Mueller, Anja, Melief, Jeroen, Maas, Roeltje, Ligtenberg, Maarten, Hansson, Johan, Offringa, Rienk, Seliger, Barbara, Poschke, Isabel, Reinherz, Ellis L, Kiessling, Rolf

Volltext

MediMer: a versatile do-it-yourself peptide-receptive MHC class I multimer platform for tumor neoantigen-specific T cell detection von Meyer, Marten, Parpoulas, Christina, Barthélémy, Titouan, Becker, Jonas P, Charoentong, Pornpimol, Lyu, Yanhong, Börsig, Selina, Bulbuc, Nadja, Tessmer, Claudia, Weinacht, Lisa, Ibberson, David, Schmidt, Patrick, Pipkorn, Rüdiger, Eichmüller, Stefan B, Steinberger, Peter, Lindner, Katharina, Poschke, Isabel, Platten, Michael, Fröhling, Stefan, Riemer, Angelika B, Hassel, Jessica C, Roberti, Maria Paula, Jäger, Dirk, Zörnig, Inka, Momburg, Frank

Volltext

Vaccination with a plasmid DNA encoding HER-2/neu together with low doses of GM-CSF and IL-2 in patients with metastatic breast carcinoma: a pilot clinical trial von Norell, Håkan, Poschke, Isabel, Charo, Jehad, Wei, Wei Z, Erskine, Courtney, Piechocki, Marie P, Knutson, Keith L, Bergh, Jonas, Lidbrink, Elisabet, Kiessling, Rolf

Volltext

T-Cell-Based Platform for Functional Screening of T-Cell Receptors Identified in Single-Cell RNA Sequencing Data Sets of Tumor-Infiltrating T-Cells von Ehrenfried, Aaron Rodriguez, Zens, Stefan, Steffens, Laura K, Kehm, Hannes, Paul, Alina, Lauenstein, Claudia, Volkmar, Michael, Poschke, Isabel, Meng, Zibo, Offringa, Rienk

Volltext

Expression patterns of the immunomodulatory enzyme arginase 1 in blood, lymph nodes and tumor tissue of early-stage breast cancer patients von de Boniface, Jana, Mao, Yumeng, Schmidt-Mende, Jan, Kiessling, Rolf, Poschke, Isabel

Volltext

807 A vaccine targeting the recurrent driver mutation H3K27M induces mutation specific T- and B- cell responses in patients with diffuse midline Gliomas von Boschert, Tamara, Lerner, Taga, Kromer, Kristina, Lindner, Katharina, Poschke, Isabel, Mildenberger, Iris, Haltenhof, Gordon, Sahm, Katharina, Lindner, John, Green, Edward, Platten, Michael

Volltext

A high‐throughput RNAi screen for detection of immune‐checkpoint molecules that mediate tumor resistance to cytotoxic T lymphocytes von Khandelwal, Nisit, Breinig, Marco, Speck, Tobias, Michels, Tillmann, Kreutzer, Christiane, Sorrentino, Antonio, Sharma, Ashwini Kumar, Umansky, Ludmila, Conrad, Heinke, Poschke, Isabel, Offringa, Rienk, König, Rainer, Bernhard, Helga, Machlenkin, Arthur, Boutros, Michael, Beckhove, Philipp

Volltext

INTERCEPT H3: a multicenter phase I peptide vaccine trial for the treatment of H3-mutated diffuse midline gliomas von Grassl, Niklas, Sahm, Katharina, Süße, Heike, Poschke, Isabel, Bunse, Lukas, Bunse, Theresa, Boschert, Tamara, Mildenberger, Iris, Rupp, Anne-Kathleen, Ewinger, Max Philipp, Lanz, Lisa-Marie, Denk, Monika, Tabatabai, Ghazaleh, Ronellenfitsch, Michael W, Herrlinger, Ulrich, Glas, Martin, Krex, Dietmar, Vajkoczy, Peter, Wick, Antje, Harting, Inga, Sahm, Felix, von Deimling, Andreas, Bendszus, Martin, Wick, Wolfgang, Platten, Michael

Volltext

Prognostic significance of tumor iNOS and COX-2 in stage III malignant cutaneous melanoma von Johansson, C. Christian, Egyházi, Suzanne, Masucci, Giuseppe, Harlin, Helena, Mougiakakos, Dimitrios, Poschke, Isabel, Nilsson, Bo, Garberg, Liss, Tuominen, Rainer, Linden, Diana, Stolt, Marianne Frostvik, Hansson, Johan, Kiessling, Rolf

Volltext